World Drug Safety Congress 2024 - Europe | Terrapinn | 8 October 2024 | Amsterdam RAI, Europaplein 24, 1078 GZ Amsterdam, Netherlands

Covering automation, quality assurance, signal management, outsourcing and medical devices in healthcare. 90+ leading solution producers to meet your needs across artificial intelligence, quality assurance and signal management to enable operational excellence. Networking is at the heart of this event. Our congress allows you to connect directly with thousands of pharma experts across 2 days of built-in 1-2-1 networking

2024 Speakers

Patrick Caubel
Chief Safety Officer, Pfizer

Minyar Chelly Kahloun
Director of QPPV-LSO & Medical Writing, ProductLife Group

Ashok Kumar Giridharilal
Principal GxP QA Auditor, RiverArk Limited

Maurice Liemburg
Director, Workflow Management, Pharmacovigilance, Astellas

Gianfranco Scibelli
Senior Director, Vault Safety, Europe, Veeva Systems

Mr Jeroen van Doorn
Director, Business System Management & Innovation, MSD

Serban Ghiorghiu
Chief Safety Officer, AstraZeneca

Mariette M Boerstoel
Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb

Martine Zimmermann
Senior Vice President, Head of Global Regulatory Affairs, IPSEN

Phil Tregunno
Deputy Director, Patient Safety Monitoring, Medicines & Healthcare Products Regulatory Agency

Kathy Roberts
Vice President, Global Pharmacovigilance, Incyte Corp.

Stewart Geary
Global Safety Officer, Eisai

Camilla Hammerum
Vice President, Head of GPS TA Oncology, Ipsen

Felix Arellano
Global Head of Pharmacovigilance and Drug Safety, Roche

Ercem Atillasoy
Chief Regulatory and Safety Officer, Jazz Pharmaceuticals

Rajakumari Long
Deputy Director, Integrated Development, Global Health, Bill and Melinda Gates Foundation

Karsten Lollike
Corporate Vice President, QPPV, Novo Nordisk

Shaloo Pandhi
Global Head, Patient Safety, Sandoz

Sarah Freestone
Vice President, Head of Pharmacovigilance and Device Safety, UCB Pharma

Fabian Heisig
Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal

Claudia Lehmann
Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International

Meenal Patwardhan
Vice President, Medical Safety Evaluation & Safety Data Sciences, AbbVie

Fabio Lievano
Vice President, Safety Science, AbbVie

Deepa Venkataraman
Vice President, Head of Global Drug Safety and Pharmacovigilance, Corcept Therapeutics

Emma Outram
Group Head, Safety Data Acquisition, Roche Products Ltd

Peter Hjelmstrom
Director and Chief Executive Officer, Uppsala Monitoring Centre

Indy Ahluwalia
PV Consultant, Truliant Consulting

Vivek Ahuja
Senior Vice President, Compliance, EVERSANA

Adriana Aristizabal
Medical Director, Vitalis

Michael Braun-Boghos
Senior Director, Safety Strategy, Oracle Health Sciences

Jorge Carmona
Global Product Line Lead, Head, Patient Safety Risk Management Informatics, Roche

Mark Cawley
Associate Director, R&D Procurement, Jazz Pharmaceuticals

Amelie Fassbender
Regional Medical Director, Developed Markets, Viatris

Kevin Fetterman
Executive Director, Orbit, Orbit By Feith Systems

Lalit Gehani
Director, Analytics and Reporting, Ultragenic

Magdalena Gielo
Manager, PV Operations, Global Submissions, Moderna

Will Gordon
Senior Vice President, Product Management, Safety, ArisGlobal LLC

Lucy Green
Director of Local Safety PV, ProductLife Group

Martin Holm-Petersen
Chief Executive Officer, Insife - Chief Strategy Officer, Qinecsa Solutions

Nawal Jebbar
QPPV & Drug Safety Manager, TFS HealthScience

Elena Jimenez Gutierrez
Senior Business Consultant, NNIT A/S

Kanwalpreet Kaur
QPPV & Head of Strategic Development Group, APCER Life Sciences

Sam Kay
Vice President, Pharma, Basil Systems

Swadhin Khawas
Global Head of Solutions and Capabilities, HCLS, WNS Global Services Ltd

Narasimha Kumar
Chief Product and Commercial Officer, Datafoundry

Robert Kyle
Vice President, Product for Pharmacovigilance, TriNetX

Nikodem Latocha
Associate Director, Computerised Systems Quality, PrimeVigilance

Maulik Mehta
President, Safety and Pharmacovigilance, TriNetX

Martha Menzel
Director, Clinical Safety, Edwards Lifesciences

Raj More
Chief Architect & CEO, RxLogix Corporation

Roger Mutter
Medical Safety Director, Alfasigma Schweiz AG

Bruce Palsulich
Vice President, Safety, Oracle Life Sciences

Abdul Rahim
Founder Director, ALWIS Solutions Limited

Hans-Jörg Römming
Executive Director, Head of GPS Operations, Merck

Griselda Saldana
Director, Global Safety, Amgen

Sarah Sendrup
CCO & Principal Consultant, Herax

Jens-Ulrich Stegmann
Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK

Ada Stelmakiene
Head of Pharmacovigilance, Insuvia

Sameer Thapar
Strategic Client Advisor, Oracle Health Sciences

Rupesh Thorat
Head, Drug Safety, SIRO Clinpharm Pvt Ltd

Koen Van der Heijden
Senior Director, EU & UK QPPV, Menarini Stemline

Sumit Verma
President, Clinical Safety and Pharmacovigilance Operations, Soterius, Inc.

Slobodan Vucinic
Senior Consultant, NNIT A/S

Robert Weber
Product Management Director, Oracle Health Sciences

Michał Zawistowski
Associate Director, Clinical Trial Safety Scientist, AstraZeneca

Mohamed Abdillahi
Director, Risk Management Product Lead, Pfizer

Esther Aparicio
Team Manager, Global Case Processing, UBC

Matt Aspinall
Head of Product & Engagement Manager, Axian Consulting Ltd.

Swapnil Babasaheb Khot
Vice President & Delivery Leader Life, Sciences Digital Operations, Cognizant

Maja Barac
Chief Executive Officer & EU QPPV, Pharmavigil

Kate Bendall
Head of Implementation, Axian Consulting Ltd.

Alex Brenchat
Vice President, Local Pharmacovigilance Services, PharmaLex

Jason Bryant
Vice President, Data & AI, ArisGlobal

Jay Dave
Technical Director, GPV & Risk Management, COD Research Pvt LTD

Francesca Dickins
Advisor, Medicines Quality Organization, Eli Lilly

Steve Dingman
Vice President, Independent PV Expert

Updesh Dosanjh
Practice Lead Safety Technology, IQVIA

Ekaterina Edle von Dall'Armi
Deputy Local QPPV & Senior Medical Advisor Patient Safety, GSK

Marie Flanagan
Director, Product Management, Safety Tech, IQVIA

Abhishek Garg
Delivery Director, Cognizant

Tanja Hoffman
Independent, Independent PV Expert

Myrto Ioannidi
Director, Global Case Processing, UBC

Maximilian Jacobs
Head of Vendor Management, Pharmacovigilance, Bayer AG

Rafael Josupeit
EEA QPPV, Procter & Gamble

Belkis Lanza
Drug Safety Coordinator, QBD Group

Dominika Łukasz
Associate Director, Clinical Trial Safety Scientist, AstraZeneca

Kausik Maiti
Executive Director, Safety Physicians, Parexel International

Sonia Mangnoesing
Director, Global Drug Safety, Arriello sro

Jose Miyar Olaiz
Senior Medical Director, Patient Safety Physician, AstraZeneca

Barry Mulchrone
Head of Safety Science & Strategy Lifecycle Safety, IQVIA

Ann-Marie Orange
Chief Information Officer and Global Head of R&D, ArisGlobal

Krupa Patel
Senior Safety Scientist, Global Patient Safety, IPSEN

Mark Perrott
Managing Partner, Axian Consulting Ltd.

Jan Petracek
Chief Executive Officer, iVigee

Iveta Petrova
Director, Product Management, Digital Science

Donald Puccio
Senior Director, Team Leader/Business Process Owner Aggregate Reports, Pfizer

Jane Reed
Director, NLP, Applied AI Science, IQVIA

Nikesh Shah
Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene

Martin Sournac
Manager, Global Pharmacovigilance Operations, Incyte

Louie Tan
Director, Medical Affairs, ClinChoice

Raj Vaghela
Chief Executive Officer, PubHive Ltd.

Valerie Vandevoorde
Executive Director, Global Pharmacovigilance Quality Head, Merck

Venkat Venkataramanan
PV Practice Lead, Life Science Operations, Cognizant

Sanjay Vyas
President, Safety & Logistics and Country Head, India, Parexel

Ajibade Adesina
Director, PV Process Excellence and Learning Strategy, Bristol-Myers Squibb

Nicole Baker
CEO, Biologit

Marta Bałuka
Manager, Global Case Management, PV Operations, Moderna

Marianne Banoub
Regional Head of PV and QA, NewBridge Pharmaceutical

Tiago Barca Ramos
Global Lead, Clinical & Drug Safety, Compliance & Operations, Swiss QPPV, Bavarian Nordic

Matteo Barion
Digital Innovation & Technologies Unit Head, QPPV Office, Chiesi Farmaceutici SpA

Isabella Caramuta
Deputy QPPV, Shionogi BV

Fabrice Besle
Director, PV Database & Analytic Reporting, Ipsen

Mayank Bhandari
Co-Founder, Sales and Business Development, Ultragenic Research & Technologies LLC

Olga Błaszczyk
Manager, Global Case Management, PV Operations, Moderna

Mircea Ciuca
Executive Director, TA Lead, Global Pharmacovigilance

Elena Prokofyeva
Head of Drug Safety Unit, FAMHP - Federal Agency for Medicines and Health Products in Belgium

Oana Rad
Senior Safety Scientist, B Braun

Tjark Reblin
Senior Vice President, Global Head of Patient Safety, Ipsen

Ranga Reddy
Head of Drug Safety Technologies, Former CSL Vifor

Nayanika Rivankar
Signal Management Strategy Lead, Merck Group

Balaji Sainath Malla
Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories Inc.

Teresa Saragoça
Technical Director and Head of Regulatory Affairs, Italfarmaco PT

Maurizio Sessa
Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen

Tim Stockley
Senior Director, Compliance and Inspection Readiness, Patient Safety, AstraZeneca

Azwi Takalani
Program Lead, HIV Vaccine Trials Network South Africa

Alina Ioana Tudor
Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin

Martijn van de Leur
Chief Operating Officer PV/RA/MI, Biomapas

Sriram Venkateswaran
Safety Data Science Director, Hoffmann la Roche Ltd

Heinz Weidenthaler
Global Principal Safety Physician, EU QPPV, Bavarian Nordic

Mark Widdowson
Senior Manager, Digital Capabilities, WorldWide Patient Safety, Bristol Myers Squibb

Fatima Bhayat
Independent PV Expert

Celine Adessi
Global Head, Clinical Sciences, Early Development Oncology, Roche

Ana Sofia Afonso
Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly

Amit Aggarwal
Executive Director, Medical Affairs & Strategic Partnerships, ABPI

Omar Aimer
Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)

Alison Allen
Director, Global Pharmacovigilance (PV) Quality Assurance, Alnylam Pharmaceuticals

Ibrahim Altamawy
Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals

Anand Ananthakrishnan
Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines

Wasim Anwar
Vice President, Deputy QPPV, Novo Nordisk A/S

Julia Appelskog
Senior Director, EU QPPV, Global Vaccine Safety, Novavax

Mina G Awad
Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International

Jamal Baig
Director, Pharmacovigilance, Multi Country Safety Head, Sanofi

Amina Baljic
Senior Director, Head, PV Operations and PV Excellence, Grunenthal

Alexandru Barbarosie
EU/UK QPPV, Global Safety Lead, Amryt Pharma

Judy Barretto
Senior Director, Virology TA, Patient Safety, Gilead

Eniko Barta Kondas
Head, Global PV Operations, Gedeon Richter PLC

Erica Bavol
Senior Director, Head of Safety Operations, Compliance and Systems, Corcept

Ricarda Berg
Head of Drug Safety Germany & Local QPPV, GSK

Majken Berghuis
Director, Pharmacovigilance, International Operations, Novo Nordisk

Kapil Bhutada
Director of Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio

Laura Paola Boga
Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé Farmaceutici SpA

Chris Bone
Director, Safety and Benefit Risk, Biogen

Emma Boulton
Director, Local Safety Operations, Mundipharma

Siva Kumar Buddha
Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.

Akhilesh Chamediya
Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion

David Chonzi
Independent Pharma Physician, Independent PV Expert

Mugdha Chopra
Co-Founder and Director, AWINSA Life Sciences

Jan Cleerbout
Deputy QPPV, Johnson & Johnson Innovative Medicine

Marco Colombati
PV Operations Manager, ITALFARMACO S.P.A.

Lynne Comiskey
Divestment Coordination Lead, Sanofi

Mark Daniels
Director, Safety Physician, Jazz Pharmaceuticals

Abiola David
Senior Director, Global Process Owner, ICSR Management, PV Operations, GSK

Anthonius de Boer
Chairman, CBG-MEB Medicines Evaluation Board

Sunita Dhar
Executive Medical Group Director, Clinical Safety, Genentech

Daniela Di Cosmo
Senior Safety Advisor, Ferring Pharmaceuticals

Elisabetta Di Martino
Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics

Shaantanu Donde
Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs, Viatris

Joan D'souza
Consultant, Independent PV Expert

Melanie Dullemond
PV Compliance Head, Medical and PV Quality, Sanofi

Phillip Eichorn
Global Head of Drug Safety, Chiesi

Sebastian Fischer
Regulatory Strategy Principal, TUV SUD Product Service GmbH

John Fitzpatrick
Senior Pharmacovigilance Manager, ProPharma

Ilana Frishman
Senior Director, Pharmacovigilance & Drug Safety, Compugen

Uwe Gudat
Chief Medical Officer, Biocon Biologics

Sibel Guerler
Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb

Israel Gutierrez
Chief Medical Officer, TLR Therapeutics

Diane Halle
Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals

Conny Johansson
Alliance Management Lead, Roche

Justin Joubert
Senior Director, Acquisitions, PV Agreements & Contract Liaison, GSK

Elena Keller
Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH

Mohammed Ali Kotal
Global Head, Medical Safety, Sandoz International GmbH

Smruti Kothari
Associate Director, PV QA, Jazz Pharmaceuticals

Marcin Kruk
Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer

Luiz Lima
Vice President, Head of Neuroscience, Global Patient Safety, IPSEN

Emanuel Lohrmann
Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals

Claire Longman
Expert Pharmacovigilance Inspector, MHRA

Valentina Mancini
Senior Director, Pharmacovigilance, EU & UK QPPV, Shionogi & TransCelerate

Monika Manske
Associate Director, Lead Quality Management and Deputy EEA QPPV, Viatris

Marcin Marciniak
Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland

Jessica Mårlind Würtele
Director, Patient Safety Excellence, AstraZeneca

Miriam Marotti
Senior Medical Director, Patient Safety Oncology, AstraZeneca

Jorgen Matz
Global Head, Pharmacovigilance & Clinical Quality, INSUD PHARMA

Sanjeev Miglani
Founder and Director, AWINSA Life Sciences

Andrew Moore
Director, PV Operations and Compliance, Takeda

Marianne Mounir
Senior Global System Auditor, Bayer

Céline Muffang
Associate Director, Medical Safety & Pharmacovigilance, AskBio

Sutirtha Mukhopadhyay
Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim

Dominic Nguyen-Van-Tam
Senior Pharmacovigilance Inspector, MHRA

Thomas Nirnberger
Chief Executive Officer, Biofi

Minhaj Obeidullah
Global Head Governance & Risk, Novartis

Tom Organ
Safety Science Director, Neuroscience TA, Global Patient Safety, IPSEN

George P. Patrinos
Professor, Department of Pharmacy & Adjunct Professor, Department of Genetics and Genomics, University of Patras & United Arab Emirates University

Anna Pelnikevich
Director, Head of Benefit-Risk Management, Merck

Emmanuelle Pinès
Head of Safety Policy & Process Oversight, QPPV Office, Janssen

Nathan Rivers
Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals

Zina Sadeq
Director, Regional PV and Alliance Management, Deputy UK QPPV, Amicus Therapeutics

Myriam Salem
National Good Pharmacovigilance Practices Inspection Program Coordinator, Health Canada

Yvonne Schäfer
Head of Patient Safety & Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International

Claudia Schaffer
Senior Director, Head of Case and Vendor Management, Merck

Olaf Schickling
Senior Director, Head of QPPV Office, BeiGene Germany GmbH

Nadine Schreiber
Head, Global Pharmacovigilance, medac GmbH

Uwe Schühly
Head of Drug Safety and Pharmacovigilance, Santhera Pharmaceuticals

Riti Shah
Senior Medical Director, Pharmacovigilance, Chiesi

Ben Kitchens
Associate Director, Medical Devices, Diagnostics Lead | Otsuka Pharmaceutical Companies (U.S.)

Kristin Knalstad
Director, Risk Management, Patient Safety | AstraZeneca

Peter Kohut
Head of Pharmacovigilance | Alvotech

Monika Kowalska
Director, Global Case Management | Moderna

Leith Kwaan
QPPV | National Bioproducts Institute NPC

Jost Leemhuis
Safety Science Partner and Global Business Lead | Roche

Rita Lobatto
Vice President, Pharmacovigilance & QPPV | Pharming Group

Asif Mahmood
Vice President, Medical Safety & Pharmacovigilance | AskBio

Asa Mattsson
Senior Director, Patient Safety Risk Management, Process & Implementation | AstraZeneca

Richard Mayer
Senior Principal Engineer, Head of Medical Safety R&D | Johnson & Johnson

Kieran O'Donnell
Director | Independent PV Expert

Karine Palin
Eu2P Programme Manager | University of Bordeaux

Nibedita Rath
Scientific Director | Open Source Pharma Foundation

Pav Rishiraj
Director, Head of Patient Safety & ABPI PV Expert Chair | Ipsen & ABPI

Hadir Rostom
Independent PV Expert - Lecturer | Modern Sciences And Arts University

Kishore Saha
Chief Specialist | Lundbeck

Gemma Sayers
Senior Director, Head, Global Development Quality Management | Regeneron Pharmaceuticals

Rudi Scheerlinck
Safety Strategy Lead | Merck Healthcare Oncology

Reinhold Schilling
Head of Global Pharmacovigilance, EU QPPV | Wörwag Pharma

Carrie Scott
Head, Global Pharmacovigilance Compliance and Policy | AbbVie

Vivien Stettner
Director, International PSEQ Strategy & Sites | AbbVie

Milos Stojkovic
Safety Process Director | Roche

Ariane Stollenwerk
Director, Head of Central Europe & Asian Int. Markets, International PhV | UCB PHARMA

Tarak Thakker
Director, Safety Systems and Reporting | BeiGene

Rebecca Webb
Senior Director, Safety, Vigilance and Medical Affairs QA | AbbVie

Monika Zych
Director, Pharmacovigilance | Baxter

Marjan Dzeparoski
RA and PV Manager | Bionika Pharmaceuticals

Maha Lakshmi Elluri
Global Safety Director, EEA/UK QPPV | Indivior Pharmaceuticals

Suzanne Foncin
Independent PV Expert

Yvonne Nanciu
Country Head, Pharmacovigilance, Deputy EU QPPV | Bayer

Claudia Pierleoni-Nielsen
Director, Global Safety Surveillance | LEO Pharma

Bert Van Leeuwen
Senior Director, Deputy QPPV | Astellas Pharma Europe BV

Heike von Treichel
Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office. Merck

2024 Sponsors

TITLE SPONSOR:
• ArisGlobal LLC

DIAMOND SPONSORS:
• Oracle
• IQVIA
• Cognizant
• Parexel
• RxLogix Corporation
• Veeva Systems

PLATINUM SPONSORS:
• Axian Consulting Ltd.
• Eversana
• Qinecsa Solutions
• ProductLife Group

GOLD SPONSORS:
• Alpha Clinical Development
• Arietta.ai
• Generis
• Insuvia
• ALWIS Solutions Limited
• Nextrove
• PubHive Ltd.
• PharSafer
• PrimeVigilance
• Pinnaxis Inc.
• Qinecsa Solutions
• Ultragenic Research & Technologies LLC
• Sophos IT Services
• SIRO Clinpharm Pvt Ltd
• TriNetX
• UBC
• Ultragenic Research & Technologies LLC
• WNS Global Services Ltd

SILVER SPONSORS:
• APCER Life Sciences
• Arriello
• AWINSA Life Sciences
• Basil Systems
• Biomapas
• Biologit
• ClinChoice
• Cogstate
• COD Research Pvt Ltd
• Datafoundry
• Digital Science
• Herax
• HCL
• PharmaLex
• Indegene Inc.
• iVigee
• NNIT A/S
• Orbit By Feith Systems
• ProPharma
• QBD Group
• Quartica, Inc.
• RiverArk Limited
• Soterius, Inc.
• TransPerfect
• Truliant Consulting